Melissa Mele Delgado
Adult Health · Williamsville, NYNPI 1972624252
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $17,713 of the $27,398 with a category attached, or 64.7%. 31 manufacturers reported payments, led by AbbVie at 27.7% of the total. 2025 is the largest year on record at $9,354, 6.8 times the $1,373 reported in 2021. Among adult health clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 960 payments — averaging $28.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$8K
- Pfizer$6K
- Johnson & Johnson$2K
- E.r. Squibb & Sons, L.L.C.$2K
- UCB, Inc.$1K
- Regeneron Healthcare Solutions, Inc.$1K
- plus $7K from 25 others
What the payments were for
- Consulting fees$3,58113%
- Speaking & faculty fees$3,48513%
- Travel & lodging$1,5476%
- Food & beverage$17,71365%
- Education$1,0724%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 195 | $7,586 |
| Pfizer | 85 | $6,284 |
| Johnson & Johnson | 132 | $2,247 |
| E.r. Squibb & Sons, L.L.C. | 67 | $2,009 |
| UCB, Inc. | 89 | $1,271 |
| Regeneron Healthcare Solutions, Inc. | 47 | $1,155 |
| Sun Pharmaceutical Industries Inc. | 49 | $1,060 |
| Sanofi | 38 | $963 |
| Amgen | 46 | $873 |
| Lilly USA, LLC | 30 | $739 |
| Novartis | 67 | $690 |
| Galderma Laboratories, L.p. | 28 | $451 |
| Incyte Corporation | 19 | $444 |
| Arcutis Biotherapeutics, Inc. | 11 | $365 |
| Dermavant Sciences, Inc. | 19 | $253 |
| LEO Pharma Inc. | 9 | $191 |
| Merz North America, Inc. | 5 | $189 |
| Sanofi-aventis U.S. LLC | 2 | $170 |
| Bristol Myers Squibb | 1 | $80 |
| Boehringer Ingelheim | 4 | $73 |
| Organon | 5 | $69 |
| Biocryst US Sales Co., LLC | 2 | $40 |
| Blueprint Medicines Corporation | 2 | $37 |
| Mallinckrodt Hospital Products Inc. | 1 | $32 |
| Smith+Nephew | 1 | $22 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $20 |
| VYNE Pharmaceuticals Inc. | 1 | $20 |
| Nobelpharma America, LLC | 1 | $18 |
| Sandoz | 1 | $17 |
| Genentech USA, Inc. | 1 | $17 |
| Botanix SB Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$27,398 in reported general payments places this provider in the 95th percentile of 3,828 adult health providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 13 | $261,957 |
| Dupixent PenDupilumab | 58 | $212,431 |
| Taltz AutoinjectorIxekizumab | 25 | $171,874 |
| Clobetasol Propionate | 207 | $7,727 |
| Metronidazole | 57 | $5,352 |
| Betamethasone Dipropionate | 110 | $5,107 |
| Dapsone | 14 | $4,170 |
| Ketoconazole | 126 | $3,245 |
| Calcipotriene | 11 | $3,164 |
| Clindamycin Phosphate | 74 | $2,553 |
| Alclometasone Dipropionate | 55 | $2,167 |
| Fluorouracil | 24 | $1,331 |
| Triamcinolone Acetonide | 74 | $1,170 |
| Imiquimod | 26 | $669 |
| Glycopyrrolate | 31 | $563 |
Paid to pharmacies, not to this prescriber.
Other adult health in Williamsville
- Ann LillisWilliamsville$15K
- Donna CatameroNew York$279K
- Kristen DurkinPort Jefferson Station$255K
- Mary CiechoskiBuffalo$200K
- Jennifer FioriniGlens Falls$151K
- Katelyn McCormackAmherst$131K
- Maria Gigante-BaggettEast Syracuse$92K
- Jane PattersonRochester$66K
- Alyson HartyNew York$65K
- Danielle BrunoPlainview$61K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.